Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'

Go back to Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'
INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) Delayed: 1.13 +0.04 (3.67%)
Previous Close $1.09    52 Week High $11.69 
Open $1.07    52 Week Low $4.50 
Day High $1.15    P/E N/A 
Day Low $1.04    EPS $-0.28 
Volume 3,973,586